Indication

Follicular lymphoma

Follicular lymphoma is a typically indolent B-cell non-Hodgkin lymphoma arising from germinal center B lymphocytes, primarily centrocytes and centroblasts. Read more about Follicular lymphoma

337 drugs 182 manufacturers

Advertisement

Drugs that treat it

Common Follicular lymphoma therapies.

Showing 82–90 of 337 drugs

PREDNISONE

PULMONARY TUBERCULOSIS·+67
ACTAVIS PHARMA,

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
ROXANE/WEST-WAR
Filter & compare in the drug finder →Opens the drug finder with Follicular lymphoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Follicular lymphoma.

Follicular lymphoma is a typically indolent B-cell non-Hodgkin lymphoma arising from germinal center B lymphocytes, primarily centrocytes and centroblasts.

It predominantly affects older adults and involves the lymphatic and hematopoietic systems, commonly presenting with painless, generalized lymphadenopathy, frequent bone marrow infiltration, and splenomegaly.

Pathophysiologically, it is defined by a nodular or follicular growth pattern and hallmark genetic alterations, most notably the t(14;18)(q32;q21) chromosomal translocation that juxtaposes the *BCL2* oncogene with the immunoglobulin heavy chain locus, leading to constitutive BCL-2 overexpression and inhibition of apoptosis.

While typically characterized by a prolonged, relapsing-and-remitting course, the disease carries an ongoing risk of histologic transformation into aggressive diffuse large B-cell lymphoma.

Personalize your experience

Follow Follicular lymphoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it